Zhang Jian, Gao Ya, Zhang Lan, Zhang Cong, Zhao Yuan, Zhang Yidan, Li Shuyue, Chang Cui, Zhang Xiangjian, Yang Guofeng
Department of Geriatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 05000, People's Republic of China.
Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People's Republic of China.
Neurotox Res. 2022 Apr;40(2):410-419. doi: 10.1007/s12640-022-00479-6. Epub 2022 Feb 11.
Accumulated oxidative damage plays key roles in the pathogenesis of Parkinson's disease (PD). Silent mating type information regulation 2 homolog 1 (SIRT1), a class III histone deacetylase, can directly activate peroxisome proliferator-activated receptor-c coactivator-1α (PGC-1α) and attenuate oxidative stress. Alpha-lipoic acid (ALA) is a natural antioxidant that has been demonstrated to protect PC12 cells against 1-methyl-4-phenylpyridinium (MPP). However, the underlying mechanisms related to changes in cell signaling cascades are not fully understood. In the present study, the neuroprotective effect of ALA and the potential role of ALA in the SIRT1 pathway was investigated in vitro and in a mouse model of PD. A Cell Counting Kit-8 (CCK-8) assay was performed to detect the SY5Y-SH cell viability. Immunohistochemistry, quantitative real-time polymerase chain reaction and western blot assays were used to evaluate the expression of tyrosine hydroxylase (TH), SIRT1, and PGC-1α in vivo and in vitro. Intracellular reactive oxygen species (ROS) production and tissue SOD and MDA were detected by the corresponding assay kits. The results showed that ALA notably prevented oxidative stress and neurotoxicity in vivo and in vitro against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)/MPP. Furthermore, ALA significantly increased the expression of SIRT1 and PGC-1α in vivo and in vitro in MPTP/MPP-induced models, which was reversed by the SIRT1 inhibitor EX527. These results suggested that ALA prevented oxidative stress and that neurotoxicity was involved in the upregulation of SIRT1 and PGC-1α in PD mice.
累积的氧化损伤在帕金森病(PD)的发病机制中起关键作用。沉默信息调节因子2同源蛋白1(SIRT1)是一种III类组蛋白脱乙酰酶,可直接激活过氧化物酶体增殖物激活受体γ共激活因子1α(PGC-1α)并减轻氧化应激。α-硫辛酸(ALA)是一种天然抗氧化剂,已被证明可保护PC12细胞免受1-甲基-4-苯基吡啶鎓(MPP)的损伤。然而,与细胞信号级联变化相关的潜在机制尚未完全明确。在本研究中,在体外和PD小鼠模型中研究了ALA的神经保护作用及其在SIRT1途径中的潜在作用。采用细胞计数试剂盒-8(CCK-8)检测SY5Y-SH细胞活力。免疫组织化学、定量实时聚合酶链反应和蛋白质印迹分析用于评估体内外酪氨酸羟化酶(TH)、SIRT1和PGC-1α的表达。通过相应的检测试剂盒检测细胞内活性氧(ROS)的产生以及组织中的超氧化物歧化酶(SOD)和丙二醛(MDA)。结果表明,ALA在体内外均能显著预防1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)/MPP诱导的氧化应激和神经毒性。此外,在MPTP/MPP诱导的模型中,ALA在体内外均显著增加了SIRT1和PGC-1α的表达,而SIRT1抑制剂EX527可逆转这种增加。这些结果表明,ALA可预防氧化应激,且神经毒性与PD小鼠中SIRT1和PGC-1α的上调有关。